Rob has over twenty years of experience in molecular biology and gene expression in the biotechnology sector. Prior to Viridos, he was a Senior Scientist at Diversa Corp., developing recombinant expression systems for industrial enzymes and animal vaccines. Earlier in his career, Rob served in senior research and science roles for Solexa Ltd. (acquired by Illumina), Dow Chemical, Chirotech Ltd., and Chiroscience Plc.

Rob received his Ph.D. in Bacterial Pathogenesis from the Centre of Microbial Research and Microbiology in the United Kingdom. He has more than twenty issued patents and additional pending applications in various areas of industrial biotechnology.